...
首页> 外文期刊>Lipids in Health Disease >The benign c.344G A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
【24h】

The benign c.344G A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia

机译:良性C.344g> a:p。(Arg115his)在LDLR基因中的变体解释了家族性高胆固醇血症的基于血库基础遗传分析

获取原文
           

摘要

We previously identified the c.344G??A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (FH). However, whether this variant affects the pathophysiology of FH remains unclear. Therefore, our aim was to annotate the c.344G??A: p.(Arg115His) variant in the LDLR gene in FH. We present 2 families harboring the c.344G??A: p.(Arg115His) variant in the LDLR gene. Genetic analyses were performed for the coding regions and the exon-intron boundary sequence of the LDLR and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes in 2 FH families. Next, the family without pathogenic variants in the LDLR and PCSK9 genes was screened by whole-exome sequencing. Detailed clinical and biochemical data were gathered from family members. In one family, the index case had biallelic c.1567G??A: p.(Val523Met) and c.344G??A: p.(Arg115His) variants in the LDLR gene, while the sibling had only the c.1567G??A: p.(Val523Met) variant in the LDLR gene. There was no difference in the FH phenotype between the siblings. In another family, the index case and the sibling had no pathogenic variants in the LDLR, PCSK9, and apolipoprotein B (APOB) genes, but the sibling’s wife with nonFH had the c.344G??A: p.(Arg115His) variant in the LDLR gene. The sibling and his wife had 4 children, including an unaffected child and an affected child who had the c.344G??A: p.(Arg115His) variant in the LDLR gene. In addition, the allele frequency of the c.344G??A: p.(Arg115His) variant (0.0023–0.0043) in Japanese and East Asian populations is relatively high compared with that of the other LDLR pathogenic variants (0.0001–0.0008). The c.344G??A: p.(Arg115His) variant in the LDLR gene is interpreted as benign in individuals with FH.
机译:我们之前鉴定了低密度脂蛋白受体(LDLR)基因中的C.344G?A:p。(Arg115HIS)变体,其基于患者的遗传分析,在Clinvar中被解释为Clinvar中的“致病性矛盾”与家族性高胆固醇血症(FH)。然而,这种变体是否影响FH的病理生理学仍然不清楚。因此,我们的目标是注释C.344G?> A:p。(Arg115his)在fh中的LDLR基因中的变体。我们展示了2个家庭,涉及C.344G?>?A:p。(Arg115His)变体在LDLR基因中。对2FH家族中LDLR和Proprotein转化酶枯草杆菌蛋白酶/ kexin型9(PCSK9)基因的编码区和外显子内边界序列进行遗传分析。接下来,通过全外壳测序筛选LDLR和PCSK9基因中没有致病变体的系列。详细的临床和生物化学数据从家庭成员收集。在一个家庭中,索引案例有双倍曲线C.1567g?>?A:p。(Val523met)和C.344g?>?A:p。(Arg115his)在LDLR基因中的变体,而兄弟姐妹只有c。 1567g?>?A:p。(val523met)LDLR基因中的变体。兄弟姐妹之间的FH表型没​​有差异。在另一个家庭中,索引案例和兄弟姐妹在LDLR,PCSK9和载脂蛋白B(Apob)基因中没有致病变异,但是兄弟姐妹的妻子患有非兄弟的妻子有C.344g?> a:p。(arg115his)变体在LDLR基因中。兄弟姐妹和他的妻子有4个孩子,包括一个不受影响的孩子和一个受影响的孩子,他们有c.344g?>?a:p。(arg115his)在ldlr基因中的变体。此外,与其他LDLR致病变种相比,日本和东亚人群中的等位基因频率为C.344G?>?A:p。(Arg115HIS)变体(0.0023-0.0043)比较较高(0.0001-0.0008) 。 C.344G?>?A:p。(Arg115His)在LDLR基因中的变体被解释为具有FH的个体中的良性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号